Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.
Krieger, Ekaterina; Kudryavtsev, Alexander; Sharashova, Ekaterina; Postoev, Vitaly; Belova, Natalia; Shagrov, Leonid; Zvedina, Julia; Drapkina, Oxana; Kontsevaya, Anna; Shalnova, Svetlana; +4 more...Brenn, Tormod; Shkolnikov, Vladimir M; Eggo, Rosalind M
; and Leon, David A
(2022)
Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.
EMERGING INFECTIOUS DISEASES, 28 (2).
pp. 463-465.
ISSN 1080-6040
DOI: 10.3201/eid2802.211640
; and Leon, David A
(2022)
Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.
EMERGING INFECTIOUS DISEASES, 28 (2).
pp. 463-465.
ISSN 1080-6040
DOI: 10.3201/eid2802.211640
Population-based data on coronavirus disease in Russia and on the immunogenicity of the Sputnik V vaccine are sparse. In a survey of 1,080 residents of Arkhangelsk 40-75 years of age, 65% were seropositive for IgG. Fifteen percent of participants had been vaccinated; of those, 97% were seropositive.
-
picture_as_pdf - Krieger_etal_2022_Seroprevalence-of-SARS-Cov-2-Antibodies.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution 4.0
Downloads